Health System

A new report by the Pharmaceutical Research & Manufacturers of America finds that there are 750 cancer drugs in development.

Bile sequestrant colesevelam now included in endocrinologist groups' diabetes guide.

The National Association of Chain Drug Stores opposes new legislation that would create a federal e-pedigree requirement for tracking and tracing pharmaceuticals.

The Office of Inspector General has issued a new guide listing standards nursing facilities must comply with.

A QualityHealth.com survey of more than 10,000 Americans found that many have cut back on their health spending due to the recession.

GlaxoSmithKline gets FDA nod for combination migraine treatment

New data show no new cases of PML in Tysabri patients

The Government Accountability Office urged Health & Human Services to prioritize practice recommendations from the Centers for Disease Control & Prevention in order to prevent hospital infections.

A survey of health plans has found that many are familiar with and make use of a formulary resource from the Academy of Managed Care Pharmacy.

Medication Dedication waives copayment generic drugs that a number of illnesses and encourages members to take prescription drugs as directed.

In a follow-up to a final rule about Medicare Part D's low-income benchmark, the Centers for Medicare & Medicaid Services said it made some mathematical errors.

NACDS supports legislation to clarify taxation of out-of-state businesses.

Express Scripts Drug Trend Report finds that the average prescription copay has dropped as generic use has gone up.

The Food & Drug Administration has asked the United States Pharmacopeia to develop more sensitive tests to detect contamination in heparin products.

Alcon has received approval for a nasal spray for allergic rhinitis called Patanase.

Medicine Shoppe and Medicap Pharmacy now have 100 stores offering specialized care for diabetes patients.

The National Association of Chain Drug Stores and the National Community Pharmacists Association criticize the Centers for Medicare & Medicaid Services' interim final rule on multiple-source drugs.

A new Institute of Medicine report warns that we need to train all our health professionals in geriatrics in preparation for the aging of our population.

The Centers for Medicare & Medicaid Services has proposed new preventable conditions for which they won't pay hospitals and new reporting requirements for quality measures.

Rx to OTC drug switches are forecast to increase in the coming years, according to a new study by Kalorama.

WellPoint's HealthCore subsidiary is building a drug safety system called Safety Sentinel System in collaboration with FDA and top academic institutions.

The Coalition Against Insurance Fraud has issued a report about the harmful effects of insurance fraud and what actions can be taken to prevent it from occurring.

Regadenoson receives FDA approval as first A2A adenosine receptor agonist for myocardial perfusion imaging.

New organization seeks to improve dignity, self-respect & integrity for pharmacy employees by focusing on improving workplace conditions.

Medicare Part D beneficiaries will see a 7.5% increase in costs in 2009.

FDA issues an early warning of progressive multifocal leukoencephalopathy associated with mycophenolate mofetil and mycophenolic acid.

Schwarz Pharma recalls rotigotine transdermal system after crystals form in patch.

The Joint Commission has issued some specific recommendations to hospitals in an effort to protect kids from drug errors.

What are the criteria necessary for insulin pump coverage? Here are some clues.

This article for the generic supplement highlights findings of an exclusive survey conducted by Advanstar for Drug Topics.